Genedx Showcases Pioneering Genomic Research and Advances in Clinical Diagnostics at ASHG Annual Meeting
Reuters
Oct 08, 2025
Genedx Showcases Pioneering Genomic Research and Advances in Clinical Diagnostics at ASHG Annual Meeting
GeneDx Holdings Corp. announced the upcoming presentation of pioneering research findings at the American Society of Human Genetics (ASHG) Annual Meeting. The company will showcase 14 research studies based on data from GeneDx Infinity™, a dataset comprising nearly one million exomes and genomes and over seven million phenotypic datapoints. Areas of focus include advancements in genomic newborn screening, neurodevelopmental disorders, diagnostic technologies, and machine learning applications in genomics. Specific presentations will cover topics such as long-read sequencing for clinical diagnostics and genetic architectures of autism and neuropsychiatric disorders. These results are scheduled to be presented during the ASHG meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251008971231) on October 08, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.